SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-08-005075
Filing Date
2008-06-18
Accepted
2008-06-18 16:30:29
Documents
3
Period of Report
2008-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8-K a5712239.htm 8-K 20685
2 EXHIBIT 10.1 a5712239_ex101.htm EX-10.1 102679
3 EXHIBIT 99.1 a5712239_ex991.htm EX-99.1 8195
  Complete submission text file 0001157523-08-005075.txt   133448
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 08905907
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1